Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Doctor & Patient: A Study in Relapsing Polychondritis

  |  Issue: December 2023  |  

Baseline tests for patients with RP should include audiometry, dynamic computed tomography (CT) of the chest and echocardiogram. Additional testing, such as laryngoscopy and bronchoscopy, may be indicated based on symptoms in specific patients.

Jason Liebowitz, MD, is an assistant professor of medicine in the Division of Rheumatology at Columbia University Vagelos College of Physicians and Surgeons, New York.

ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Ferrada M, Rimland CA, Quinn K, et al. Defining clinical subgroups in relapsing polychondritis: A prospective observational cohort study. Arthritis Rheumatol. 2020 Aug;72(8):1396–1402.
  2. Dion J, Costedoat-Chalumeau N, Sène D, et al. Relapsing polychondritis can be characterized by three different clinical phenotypes: Analysis of a recent series of 142 patients. Arthritis Rheumatol. 2016 Dec;68(12):2992–3001.
  3. Beck DB, Ferrada MA, Sikora KA, et al. Somatic mutations in uba1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020 Dec 31;383(27):2628–2638.

Related Articles

    Pulmonary Compromise Leads to Relapsing Polychondritis Diagnosis

    Relapsing polychondritis (RPC) is a systemic and, in some cases, fatal disease. Dyspnea with findings of small airway disease—even in the absence of the more commonly associated tracheobronchial abnormalities or pathognomonic clinical findings, such as saddle nose and cauliflower ear—may be presenting signs and symptoms of relapsing polychondritis. Below, we present a case demonstrating that…

    The 2018 ARHP Merit Awards & ACR Distinguished Fellows

    CHICAGO—At the 2018 ACR/ARHP Annual Meeting in October, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARHP Merit Awards about their individual contributions to advancing rheumatology. You’ll also find interviews…

    Dana Robochek / shutterstock.com

    VEXAS: A Newly Identified & Vexing Myeloid-Driven Inflammation

    A large, international team of rheumatologists, geneticists, hematologists and other researchers has discovered a severe inflammatory syndrome linked to an acquired genetic mutation in the bone marrow of older men. The X-linked syndrome, they found, is caused by a somatic mutation in myeloid stem cells that hobbles the master regulator of a pathway tasked with…